On Friday, Lonza announced plans to construct a large-scale commercial drug product fill and finish facility in the town of Stein, Switzerland.

Lon­za to in­vest $500M+ on fill-fin­ish fa­cil­i­ty on its home turf

Lon­za has been ex­pand­ing its reach across the globe, bring­ing sites in Chi­na and the US on­line this year, but now they are look­ing clos­er to home for their next ma­jor in­vest­ment.

The Swiss man­u­fac­tur­er on Fri­day an­nounced plans to con­struct a large-scale com­mer­cial drug fill and fin­ish fa­cil­i­ty in the town of Stein, Switzer­land. The new fa­cil­i­ty will be de­liv­ered through an in­vest­ment of ap­prox­i­mate­ly CHF 500 mil­lion, or $519 mil­lion, and is ex­pect­ed to be com­plet­ed in 2026. The fa­cil­i­ty will al­so be con­struct­ed on the same cam­pus as Lon­za’s cur­rent clin­i­cal drug prod­uct fa­cil­i­ty.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.